You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

muscle invasive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • Chengdu, Sichuan, China
    West China Hospital
Aug 10, 2023

Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Apr 11, 2023

    Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

    Completed
    • Urinary Bladder Cancer
    • +4 more
    • Neutrophil to lymphocyte ratio
    • Cairo, Egypt
      Ain Shams university
    Jul 15, 2023

    Non-muscle Invasive Bladder Cancer Trial (TARA-002)

    Not yet recruiting
    • Non-muscle Invasive Bladder Cancer
    • TARA-002
    • (no location specified)
    Jul 14, 2023

    Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

    Recruiting
    • Non Muscle Invasive Bladder Cancer
    • N803 plus Bacillus Calmette-Guerin (BCG)
    • Honolulu, Hawaii
      Island Urology
    Aug 7, 2023

    Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

    Not yet recruiting
    • Non-Muscle- Invasive Bladder Cancer
    • Durvalumab
    • BCG
    • (no location specified)
    Jul 5, 2023

    Nivolumab in Japanese Muscle-invasive Urothelial Carcinoma

    Not yet recruiting
    • Muscle-invasive Urothelial Carcinoma
      • City, State, Japan
        Local Institution
      Mar 20, 2023

      Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

      Recruiting
      • Bladder Cancer
      • Pseudomonas aeruginosa
      • Jinan, Shandong, China
        Qilu hospital
      Jul 26, 2023

      Muscle Invasive Bladder Carcinoma Trial in Beijing (RC48-ADC, AK104)

      Recruiting
      • Muscle Invasive Bladder Carcinoma
      • Beijing, China
        Cancer Institute and Hospital, Chinese Academy of Medical Scienc
      Oct 6, 2023

      Non-muscle-invasive Bladder Cancer Trial (Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test)

      Not yet recruiting
      • Non-muscle-invasive Bladder Cancer
      • Cystoscopy
      • +2 more
      • (no location specified)
      Apr 4, 2023

      Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

      Not yet recruiting
      • Non-muscle-invasive Bladder Cancer
      • +2 more
      • PDD-TURBT with hexaminolevulinate (Hexvix®)
      • Power Led Saphira (TM) from KARL STORZ
      • (no location specified)
      Jul 24, 2023

      BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder

      Recruiting
      • Bladder Cancer
        • Little Rock, Arkansas
        • +2 more
        Aug 6, 2023

        Uromonitor asBiomarker for Optimization of NMIBC Management by

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
          • (no location specified)
          May 9, 2023

          Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

          Not yet recruiting
          • Muscle-Invasive Bladder Carcinoma
          • +2 more
          • Guangzhou, Guangdong, China
            Cancer Center, Sun Yat-sen University
          Aug 3, 2023

          Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma Trial in Cleveland (Sacituzumab

          Not yet recruiting
          • Localized Muscle Invasive Bladder Urothelial Carcinoma
          • Muscle-Invasive Bladder Carcinoma
          • Sacituzumab govitecan
          • Adaptive Radiotherapy
          • Cleveland, Ohio
            Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
          Apr 18, 2023

          Muscle-Invasive Bladder Carcinoma, Chemo Effect, Surgery Trial in Rome (cisplatin based neoadjuvant chemo, Radical cystectomy

          Recruiting
          • Muscle-Invasive Bladder Carcinoma
          • +2 more
          • cisplatin based neoadjuvant chemotherapy
          • Radical cystectomy alone
          • Rome, Italy
            Riccardo Mastroianni
          Mar 8, 2023

          Mood Alterations in Non-Muscle Invasive Bladder Cancer Treated

          Recruiting
          • Non-Muscle Invasive Bladder Cancer
          • Questionnaires
          • +4 more
          • Washington, District of Columbia
            Sibley Memorial Hospital
          Jan 17, 2023

          ctDNA in Muscle-invasive Bladder Cancer Treated With Trimodality

          Recruiting
          • Bladder Cancer
          • Muscle-Invasive Bladder Carcinoma
            • Chapel Hill, North Carolina
              North Carolina Cancer Hospital (UNC)
            Jan 11, 2023

            Bladder Cancer Trial in Tianjin (Cadonilimab)

            Recruiting
            • Bladder Cancer
            • Tianjin, Tianjin, China
              Tianjin Medical University Second Hospital
            Aug 23, 2023

            Non-Muscle Invasive Bladder Cancer, Self Efficacy, Smoking Behaviors Trial in Istanbul (Behavioral: Motivational Interviewing

            Not yet recruiting
            • Non-Muscle Invasive Bladder Cancer
            • +4 more
            • Behavioral: Motivational Interviewing with WhatsApp video call
            • Istanbul, Turkey
              İrem Nur Ozdemir
            Jan 20, 2023

            Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity

            Recruiting
            • Muscle-Invasive Bladder Carcinoma
            • Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing
            • Beijing, Beijing, China
              Chinese PLA General Hospital
            Mar 11, 2023

            Predicting Post-cystectomy Outcome in Muscle Invasive Bladder

            Recruiting
            • Bladder Cancer
            • develop and validate a deep learning radiomics model based on preoperative enhanced CT image
            • Chongqing, Chongqing, China
              Department of Urology, The First Affiliated Hospital of Chongqin
            Oct 18, 2023

            Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

            Active, not recruiting
            • Non-muscle-invasive Bladder Cancer
            • Gemcitabine 1000 mg, Docetaxel 37.5g
            • Zagreb, Croatia
              University Hospital Centre Zagreb
            Jan 20, 2023

            Analytical Specificity of Bladder EpiCheck Test in Healthy

            Completed
            • Non Muscle Invasive Bladder Cancer
            • Non-Muscle Invasive Bladder Urothelial Carcinoma
            • Bladder EpiCheck
            • San Antonio, Texas
              Urology San Antonio
            Sep 3, 2023